Paper28933751
Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase.
Stojan J. Molecules, 2017. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase. Papers, record 28933751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28933751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rapid Mechanistic Evaluation and Parameter Estimation of Putative Inhibitors in a Single-Step Progress-Curve Analysis: The Case of Horse Butyrylcholinesterase.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Butyrylcholinesterase | Major topic |
| Butyrylthiocholine | Major topic |
| Cholinesterase Inhibitors | Major topic |
| Animals | |
| Horses | |
| Kinetics | |
| Ligands | |
| Models, Biological | |
| Sodium Fluoride |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21091433 | X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger. | Biochem J | 2011 | https://conductscience.org/library/papers/21091433 | PubMed |
| 2 | 5963443 | Chemical structure and function of the active center of acetylcholinesterase. | Biochemistry | 1966 | https://conductscience.org/library/papers/5963443 | PubMed |
| 3 | 15304240 | Cholinesterase inhibitors: new roles and therapeutic alternatives. | Pharmacol Res | 2004 | https://conductscience.org/library/papers/15304240 | PubMed |
| 4 | 25226236 | Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. | J Med Chem | 2014 | https://conductscience.org/library/papers/25226236 | PubMed |
| 5 | 28000737 | Development of an in-vivo active reversible butyrylcholinesterase inhibitor. | Sci Rep | 2016 | https://conductscience.org/library/papers/28000737 | PubMed |
| 6 | 4000107 | The slow rate of inhibition of acetylcholinesterase by fluoride. | Mol Pharmacol | 1985 | https://conductscience.org/library/papers/4000107 | PubMed |
| 7 | 15030487 | Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrate. | Eur J Biochem | 2004 | https://conductscience.org/library/papers/15030487 | PubMed |
| 8 | 891 | Acetylcholinesterase. | Adv Enzymol Relat Areas Mol Biol | 1975 | https://conductscience.org/library/papers/891 | PubMed |
| 9 | 11856351 | Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion. | Eur J Biochem | 2002 | https://conductscience.org/library/papers/11856351 | PubMed |
| 10 | 12941576 | Treatment of Alzheimer's disease: current status and new perspectives. | Lancet Neurol | 2003 | https://conductscience.org/library/papers/12941576 | PubMed |
| 11 | 19627979 | Application of the Van Slyke-Cullen irreversible mechanism in the analysis of enzymatic progress curves. | Anal Biochem | 2009 | https://conductscience.org/library/papers/19627979 | PubMed |
| 12 | 27858711 | Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates. | J Alzheimers Dis | 2017 | https://conductscience.org/library/papers/27858711 | PubMed |
| 13 | 22630075 | The integrated Michaelis-Menten rate equation: déjà vu or vu jàdé? | J Enzyme Inhib Med Chem | 2013 | https://conductscience.org/library/papers/22630075 | PubMed |
| 14 | 3982389 | Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding. | Mol Pharmacol | 1985 | https://conductscience.org/library/papers/3982389 | PubMed |
| 15 | 9890890 | Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. | Biochemistry | 1999 | https://conductscience.org/library/papers/9890890 | PubMed |
| 16 | 26632651 | Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography. | J Med Chem | 2016 | https://conductscience.org/library/papers/26632651 | PubMed |
| 17 | 1001690 | Design and analysis of progress curves in enzyme kinetics. | Biochem Soc Trans | 1976 | https://conductscience.org/library/papers/1001690 | PubMed |
| 18 | 11259830 | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11259830 | PubMed |
| 19 | 8415649 | Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8415649 | PubMed |
| 20 | 23279886 | The significance of low substrate concentration measurements for mechanistic interpretation in cholinesterases. | Chem Biol Interact | 2013 | https://conductscience.org/library/papers/23279886 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35563466 | Kinetic Modeling of Time-Dependent Enzyme Inhibition by Pre-Steady-State Analysis of Progress Curves: The Case Study of the Anti-Alzheimer's Drug Galantamine. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563466 | PubMed |
| 35209091 | The Removal of Time-Concentration Data Points from Progress Curves Improves the Determination of Km: The Example of Paraoxonase 1. | Molecules | 2022 | https://conductscience.org/library/papers/35209091 | PubMed |
| 31914836 | Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes. | J Enzyme Inhib Med Chem | 2020 | https://conductscience.org/library/papers/31914836 | PubMed |
| 31426402 | New Sesquiterpenoids from the Fermented Broth of Termitomyces albuminosus and their Anti-Acetylcholinesterase Activity. | Molecules | 2019 | https://conductscience.org/library/papers/31426402 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BCHE | 590 | PubTator's text mining | https://conductscience.org/library/genes/590 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28933751
GET https://conductscience.org/api/papers/v1/28933751/references?page=2